AcuraStem Lands $4 Million CIRM Grant to Transform ALS and FTD Treatment
AcuraStem, a leading biotechnology firm renowned for its patient-centered approach to treating neurodegenerative disorders, has announced a pivotal development in its research efforts. The company has been awarded $4 million in grant funding by the California Institute for Regenerative Medicine (CIRM). This substantial investment will bolster AcuraStem’s innovative work on its targeted therapeutic program focusing…